Microultrasonography-guided biopsy offered comparable detection as MRI/conventional ultrasound-guided biopsy in detection of Gleason grade group 2 or higher prostate cancer, according to a new international multicenter study.
The Invenia ABUS Premium device reportedly offers consistent high-resolution imaging and up to a 40 percent increase in scan speeds for women with dense breasts.
Emphasizing intuitive workflow and portability, the Universal Wireless Probe reportedly offers a cost-effective combination of phased and linear ultrasound imaging.
Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.
In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.